Loading...
Proteomics Placements And New Platform Pipeline Will Reshape Long-Term Potential
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
-11.9%7D
9.7%1Y
-11.9%7D
9.7%You can edit this narrative until Jan 9 6:10 AM. Then, changes will post as Updates.